医疗创新ETF(516820)连续3天净流入，医疗器械板块持续活跃

Group 1 - The core viewpoint of the articles highlights the positive momentum in the medical and healthcare innovation sector, driven by policy support and technological advancements, particularly in the brain-computer interface market [2][3] - The China Securities Medical and Medical Device Innovation Index (931484) has shown a slight increase of 0.03%, with notable gains from specific stocks such as Teva Bio, which rose by 3.38%, and Ganli Pharmaceutical, which increased by 2.24% [1] - The Medical Innovation ETF (516820) has experienced continuous net inflows over the past three days, totaling 11.24 million yuan, with a peak single-day inflow of 6.0262 million yuan [1] Group 2 - The National Healthcare Security Administration has released a guideline establishing 37 pricing projects for surgical and treatment auxiliary services, which includes advanced technologies such as 3D printing and robotic surgery [1] - The brain-computer interface sector is expected to commercialize rapidly due to a combination of supportive policies and technological breakthroughs, with non-invasive technologies gaining traction for their safety and cost-effectiveness [2] - The top ten weighted stocks in the China Securities Medical and Medical Device Innovation Index account for 63.75% of the index, indicating a concentrated investment in leading companies within the sector [3]